Feb 22, 2019 - Putnam Fl Investment Management Co Buys Amgen Inc, CVS Health Corp, Cisco Systems Inc, Sells Aetna Inc, Invesco QQQ Trust Series 1, Facebook Inc, Stocks: AMGN,CVS,CSCO,IEFA,DRI,BAC,MAS,PBCT,MDT,XLE,AJG,BH, release date:Feb 22, 2019
Feb 22, 2019 - Amgen (AMGN) and partners started enrollment for the second phase III study of omecamtiv mecarbil, which is being developed for the potential treatment of heart failure with reduced ejection fraction.
Feb 21, 2019 - The Zacks Analyst Blog Highlights: Walmart, Amgen, Honda, TransCanada and TransUnion
Feb 21, 2019 - Merck's (MRK) sBLA looking for approval of Keytruda monotherapy for the third-line treatment of small cell lung cancer, a difficult-to-treat cancer, gets FDA's priority review.
Feb 20, 2019 - Top Analyst Reports for Walmart, Amgen and Honda
Feb 20, 2019 - Merck's (MRK) Keytruda fails a phase III study in second-line advanced hepatocellular carcinoma (HCC). It gets FDA approval for the adjuvant treatment of patients with high-risk stage III melanoma.
Feb 19, 2019 - The FDA accepts Roche's (RHHBY) BLA for polatuzumab vedotin and NDAs for entrectinib, and grants Priority Review status to the applications.
Feb 19, 2019 - Many dividend growth investors seek the highest-quality companies.Independent data providers such as S&P, Morningstar, and Simply Safe Dividends offer rankings of quality factors.A simple scoring syst
Feb 18, 2019 - Merck's (MRK) sBLA looking for approval of Keytruda plus Pfizer's Inlyta for the first-line treatment of the most common type of kidney cancer gets FDA's priority review.
Feb 16, 2019 - Regeneron Pharmaceuticals (NASDAQ:REGN) and development partner Sanofi (NASDAQ:SNY) announce that the USPTO has invalidated 17 claims as obvious of U.S. Patent No. 8,679,487 owned by Amgen's (NASDAQ:A